HYPERPHAGIA IN PRADER-WILLI SYNDROME
Clinical trials for HYPERPHAGIA IN PRADER-WILLI SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HYPERPHAGIA IN PRADER-WILLI SYNDROME trials appear
Sign up with your email to follow new studies for HYPERPHAGIA IN PRADER-WILLI SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests nasal spray for debilitating hunger disorder
Disease control ENROLLING_BY_INVITATIONThis study continues testing a nasal spray called carbetocin for people with Prader-Willi syndrome who struggle with extreme, constant hunger. It's for 160 participants who finished a previous 12-week trial to check long-term safety and side effects. The spray is given three time…
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 02, 2026 06:56 UTC
-
New drug trial aims to tame uncontrollable hunger in rare genetic disorder
Disease control TerminatedThis study is testing whether ARD-101 can safely help control the extreme, life-threatening hunger experienced by people with Prader-Willi syndrome over a full year. It follows 90 patients who previously participated in a related 12-week trial, asking them to take the medication …
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New nasal spray aims to tame Life-Threatening hunger in rare genetic disorder
Symptom relief OngoingThis study is testing whether a carbetocin nasal spray can reduce the constant, extreme hunger (hyperphagia) that is the most challenging symptom of Prader-Willi syndrome (PWS). About 170 participants, aged 5 to 30, will use the spray or a placebo for 12 weeks. The main goal is t…
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Mar 25, 2026 14:09 UTC